300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Email
Big Data
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Artificial Intelligence
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Croatia
Togo
Guinea
Haiti
Kyrgyzstan
Norway
Iran
Lesotho
Liberia
Isle of Man
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Pakistan
Sudan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Namibia
Panama
Nicaragua
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Morocco
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
David Blivin, President & CEO at Cottonwood Technology Fund

David Blivin

President & CEO @ Cottonwood Technology Fund

Santa Fe, United States

David Blivin is a Series A investor at Cottonwood Technology Fund in Santa Fe focused on Biotechnology and Manufacturing. Dave is co-founder and a managing director of Cottonwood Technology Fund. Cottonwood Technology Fund is focused on early/seed stage companies and brings with it an extensive network to additional capital and strategic customers/partners. Dave has experience working with the national labs and the research universities throughout thesouthwest at the leadership and research head levels. Prior to co-founding Cottonwood Technology Fund, Dave founded and served as Managing Director of Southeast Interactive, the first and largest information technology-focused fund based in the Southeast. While at Southeast Interactive (SEI), Dave was responsible for raising three funds totaling over $175 million. He was directly involved in fund raising and exit transaction events totaling in excess of $1 billion across the SEI portfolio and generated cash on cash returns on his directed investments of approximately 4X. Dave holds a MBA from the Fuqua School of Business at Duke University.

Total investments:
28
Last investment:
Lead investor:
61%

Last updated:

Industries David Blivin invests in

BiotechnologyManufacturingMedicalChemicalHealth Care

Stages David Blivin invests in

Series ASeedSeries BSeries CDebt Financing

Countries David Blivin invests in

United StatesThe Netherlands

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 4 (14%)
  • Manufacturing 4 (14%)
  • Medical 3 (11%)
  • Chemical 3 (11%)
  • Health Care 3 (11%)
See all 27 industries →

Stage

  • Series A 8 (29%)
  • Seed 4 (14%)
  • Series B 3 (11%)
  • Series C 2 (7%)
  • Debt Financing 2 (7%)
See all 8 stages →

Country

  • United States 11 (39%)
  • The Netherlands 2 (7%)

Investments

CompanyDescriptionRoundLinks
Green Theme Technologies is a developer of environmentally-friendly, dry textile finishing technology. It is a textile innovation company with the mission to create products that out-perform existing technologies while eliminating water usage and pollution. The company was founded in 2012 and is based in Rio Rancho, New Mexico. $6M / Series C / Nov 06, 2024
Green Theme Technologies is a developer of environmentally-friendly, dry textile finishing technology. It is a textile innovation company with the mission to create products that out-perform existing technologies while eliminating water usage and pollution. The company was founded in 2012 and is based in Rio Rancho, New Mexico. $5.4M / Series B / Oct 07, 2022
BioFlyte is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to our safety and security.Our products are designed to autonomously sample ambient air, for example, in critical infrastructure, but can also accept liquid or powder samples manually. $6.1M / Series A / Apr 19, 2022
mPower Technology is an innovative solar cell technology startup.They are an experienced team of technology innovators and industry veterans out to shape the future of solar power around the globe. $10M / Series B / Feb 01, 2022
Circular Genomics develops circular RNA (circRNA)-based diagnostic and biomarker tools for neurological and psychiatric disorders. The company uses brain-derived circRNAs, a class of stable non-coding RNA molecules enriched in the brain, to build blood-based assays that reflect disease biology in real time. Its first product, MindLight™, predictswhether a patient with major depressive disorder will respond to SSRI antidepressants. Circular Genomics is also creating additional assays designed for early detection and risk prediction of neurodegenerative diseases such as Alzheimer’s disease. The company applies its circRNA platform to help clinicians make more informed treatment decisions using molecular indicators of brain health. $4.5M / Seed / Dec 14, 2021
mPower Technology is an innovative solar cell technology startup.They are an experienced team of technology innovators and industry veterans out to shape the future of solar power around the globe. $1.9M / Series A / Mar 24, 2020
Eurekite is a scientific and creative company with expertise in formulation chemistry, production technology, and composite development.The company was incorporated in May 2015 as a spin off from the university to further develop and commercialize the technology. The disruptive flexible ceramic technology attracted Cottonwood Technology Fund, atop performing early stage VC firm from U.S.Eurekite’s birthplace is the University of Twente, which is located in Enschede, The Netherlands. The Flexiramics® technology was developed at the Inorganic Materials Science Group (IMS) of MESA + Institute for Nanotechnology, under the supervision of Prof. Andre ten Elshof. $1.8M / Series A / Aug 01, 2018
Flexiramics combines ceramic properties such as heat resistance and chemical stability with the flexibility and lightweight characteristics typically associated with polymers. The company supports use cases including high-frequency electronics, thermal management, battery components, and advanced filtration media. It collaborates with partners toco-develop materials tailored to specific performance and manufacturing requirements. Its offerings also extend to advisory and technical support for integrating these materials into commercial products. $1.9M / Series A / Aug 01, 2018
Eurekite is a scientific and creative company with expertise in formulation chemistry, production technology, and composite development.The company was incorporated in May 2015 as a spin off from the university to further develop and commercialize the technology. The disruptive flexible ceramic technology attracted Cottonwood Technology Fund, atop performing early stage VC firm from U.S.Eurekite’s birthplace is the University of Twente, which is located in Enschede, The Netherlands. The Flexiramics® technology was developed at the Inorganic Materials Science Group (IMS) of MESA + Institute for Nanotechnology, under the supervision of Prof. Andre ten Elshof. $1.3M / Seed / Sep 11, 2015
Flexiramics combines ceramic properties such as heat resistance and chemical stability with the flexibility and lightweight characteristics typically associated with polymers. The company supports use cases including high-frequency electronics, thermal management, battery components, and advanced filtration media. It collaborates with partners toco-develop materials tailored to specific performance and manufacturing requirements. Its offerings also extend to advisory and technical support for integrating these materials into commercial products. $1.3M / Seed / Sep 11, 2015
See all 28 investments →

Co-Investors

Cottonwood Technology Fund

About Cottonwood Technology Fund

VC Fund · Santa Fe, United States

Cottonwood Technology Fund is a venture capital firm that focuses on high-tech / deeptech investments. It focuses on investing in patent-based high-tech and hardware startups Sectors: robotics, photonics, optics, nanotech, sensor tech, telecom, automotive, cleantech, green energy, Medtech, chemicals, and advanced materials.The company wasfounded in 2010 and headquartered in New Mexico, United States.

Cottonwood Technology Fund Contacts

NameEmailPhoneSocials
Alain le Loux
Alain le Loux General Partner
David Blivin
David Blivin President & CEO
Alan Abbott
Alan Abbott Special Limited Partner
Charles Call
Charles Call Special Limited Partner
Matthew Ongaro
Matthew Ongaro Junior Partner

Sign up to unlock verified contacts

Unlock Contacts

See all 7 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Email
Big Data
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Artificial Intelligence
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Croatia
Togo
Guinea
Haiti
Kyrgyzstan
Norway
Iran
Lesotho
Liberia
Isle of Man
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Pakistan
Sudan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Namibia
Panama
Nicaragua
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Morocco
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does David Blivin invest in?

David Blivin invests primarily in Biotechnology, Manufacturing and Medical startups, most often at Series A and Seed stage. Most of the 28 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact David Blivin?

Public channels for David Blivin include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did David Blivin last invest?

The most recent investment recorded for David Blivin closed in Nov 2024. Shizune tracks 28 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
David Blivin David Blivin Find email